for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Shanghai Shenqi Pharmactcl Inv Mgt CoLtd

600613.SS

Latest Trade

7.05CNY

Change

-0.19(-2.62%)

Volume

4,538,752

Today's Range

6.98

 - 

7.24

52 Week Range

4.55

 - 

11.01

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
7.24
Open
7.22
Volume
4,538,752
3M AVG Volume
147.69
Today's High
7.24
Today's Low
6.98
52 Week High
11.01
52 Week Low
4.55
Shares Out (MIL)
534.07
Market Cap (MIL)
3,808.28
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Shanghai Shenqi Pharmaceutical's Shareholder Signs Agreement To Sell Shares In The Company

Shanghai Shenqi Pharmaceutical Investment Management to pay div for FY 2017 on July 27 for A share and Aug. 10 for B share

Shanghai Shenqi Pharmaceutical Investment's Two Shareholders Plan To Unload Stakes

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Shanghai Shenqi Pharmactcl Inv Mgt CoLtd

Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Company’s products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of oncology, antifungal, antipyretic and gynaecology. The Company's main products include cantharidin sodium vitamin B6 injection, cantharidin sodium injection and other Chinese patent drug products. The Company distributes its products in domestic market.

Industry

Biotechnology & Drugs

Contact Info

Room 613

Changfa Tower, No. 128, Weihai Road

+86.21.53750009

http://www.gzsq.com/

Executive Leadership

Taotao Zhang

Chairman of the Board

Chongxia Gang

Chief Financial Officer

Bin Feng

General Manager, Director

Kejing Wu

Secretary of the Board

Xianjia Ka

Director

Key Stats

Price To Earnings (TTM)
39.28
Price To Sales (TTM)
1.97
Price To Book (MRQ)
1.51
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
2.23
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
3.67
Return on Equity (TTM)
2.90

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up